Well Health - Digitale Services für die Medizin (Seite 10)

[Gabrielah]

WELL Health Technologies tritt einem Projekt von Digital Technology Supercluster bei

https://themarketherald.de/well-health-technologies-wkn-a2jq…

Hier findet ihr deutsche Artikel von australischen und kanadischen Unternehmen

[winston-wolfe]

WELL Health (TSX:WELL) joins Digital Technology Supercluster Project

WELL Health Technologies (WELL) has joined a Digital Technology Supercluster (DTS) project called Health Compass.
Health Compass applies artificial intelligence to existing EMRs, helping physicians find the insights they need.
Having secured $3M in funding, WELL’s platform will be used to pilot the Health Compass project. The Health Compass solution will help physicians sort through large amounts of data.
WELL is a provider-focused digital healthcare company that has built a practitioner enablement platform that provides practice management tools.
...
“This project is developing technology that has the potential to connect patients with life-changing care more quickly,” said the Honourable François-Philippe Champagne, Minister of Innovation, Science, and Industry."
“Our government is proud to support the Digital Technology Cluster and its partners, as their new Health Compass solution will help physicians sort through large amounts of data, making it easier and faster for them to make critical decisions for their patients.”
...
https://themarketherald.ca/well-health-tsxwell-joins-digital…

[winston-wolfe]

Well Health is a top TSX growth stock

...
Deploying an acquisition-based business model, the company has increased sales from $10.6 million in 2018 to $302.3 million in 2021. Better still, Well Health expects to end 2022 with sales of $565 million. Comparatively, its bottom line could improve from an adjusted EBITDA (earnings before interest, tax, depreciation and amortization) loss of $1.2 million in 2018 to an EBITDA profit of $100 million in 2022. WELL Health expects to end 2023 with an annual revenue run rate of $700 million.

WELL Health aims to leverage technology and positively impact health outcomes by empowering health practitioners and their patients. It has successfully created a robust end-to-end healthcare system in Canada. South of the border, it provides omnichannel healthcare services and solutions in specialized markets.

WELL Health emphasized that more than 21,000 practitioners purchase its products or services and its annual run rate for patient interactions stood at 4.7 million. Over 90% of the company’s revenues are of a recurring nature, enabling WELL Health to generate cash flows across market cycles.
...
Given Bay Street’s revenue estimates for 2023, WELL stock is priced at less than 1 times sales, which is really cheap for a profitable growth stock. Analysts tracking the company remain bullish on WELL Health and expect shares to rise by almost 200% in the next 12 months.
...
https://www.fool.ca/2022/12/20/is-well-health-stock-a-buy-in…

[winston-wolfe]

Here’s Why I Just Bought WELL Health Stock

Although there are several high-quality stocks you buy undervalued today, WELL Health Technologies has to be one of the best.

WELL continues to smash expectations

Although stocks all year, especially tech stocks, have been losing value, WELL’s core business continues to grow at an exceptional pace. In fact, WELL has performed so well this year that it’s actually increased its full-year guidance several times and continues to beat expectations at each quarterly earnings report.

Initially, WELL was expected to do about $500 million in sales for the full year of 2022. That expectation has increased on multiple occasions, and now WELL expects it will do roughly $565 million in revenue this year.

However, in addition to the impressive top-line growth, WELL is also managing to keep its margins intact. Therefore, the guidance for its full-year earnings before interest, taxes, depreciation and amortization (EBITDA) has increased as well.
...
https://www.fool.ca/2022/11/28/heres-why-i-just-bought-well-…

[winston-wolfe]

Die WELL Health-Aktie hat vor kurzem ihre Ergebnisse veröffentlicht, und die Ergebnisse waren wieder einmal rekordverdächtig. Das Unternehmen erzielte einen Rekord-Quartalsumsatz von 145,8 Mio. USD, was einer Steigerung von 47 % gegenüber dem Vorjahr entspricht. Und dies nicht nur aufgrund von Akquisitionen, sondern auch aufgrund von organischem Wachstum.

Die WELL Health-Aktie erzielte auch einen Rekordzuwachs beim bereinigten Gewinn vor Zinsen, Steuern und Abschreibungen (EBITDA) in Höhe von 27,5 Millionen US-Dollar, was einem Anstieg von 23 % gegenüber dem Vorjahr entspricht. Die virtuellen Dienstleistungen stiegen um 75 %, und all dies zusammen veranlasste das Unternehmen, seine Prognose für 2022 zu erhöhen.

Die virtuelle Gesundheitsplattform rechnet nun mit einem Umsatz von mehr als 565 Mio. US-Dollar, gegenüber 550 Mio. US-Dollar. Dies ist die vierte Anhebung der Prognosen für WELL in Folge. Und das alles in einem Zeitraum, der für die Aktie eigentlich ein "schlechter" Performance-Zeitraum sein sollte.

Es wird noch mehr kommen

Aber hier ist die Sache. Das ist nicht einmal der Grund, warum ich die WELL Health-Aktie im Moment halte. Ja, ich will Wachstum. Ja, ich möchte eine starke Leistung sehen. Aber all das spielt keine Rolle, wenn es für dieses Unternehmen keine Zukunft gibt, und die gibt es durchaus.

Die Pandemie hat eine Gelegenheit für ein massives Wachstum im Bereich der virtuellen Gesundheitsfürsorge geschaffen, und diese wird heute mehr denn je benötigt. Ländliche Gemeinden, die keinen Arzt erreichen können, haben jetzt die Möglichkeit, einen virtuellen Arzt zu erreichen. Das spart Zeit und, was ebenso wichtig ist, auch Geld. Und da unser Land weiterhin mit einer Krise im Gesundheitswesen konfrontiert ist, werden virtuelle Besuche in absehbarer Zukunft von unglaublicher Bedeutung bleiben.

In Anbetracht all dessen ist die WELL Health-Aktie meiner Meinung nach ein Top-Kauf. Ich kaufe die Aktie weiterhin zu niedrigen Kursen, wohl wissend, dass diese Rekordleistung irgendwann zu einer Trendwende führen wird. Diese Aussichten sind besonders vielversprechend für langfristig orientierte Anleger, was ich zu sein gedenke.

Übersetzt mit www.DeepL.com/Translator
...
https://www.fool.ca/2022/11/17/why-i-own-well-health-stock/

[winston-wolfe]

WELL Health meldet Ergebnis für das dritte Quartal und für die Periode Q1 - Q3 2022

noch mal auf deutsch

https://de.marketscreener.com/kurs/aktie/WELL-HEALTH-TECHNOL…

[winston-wolfe]

WELL Health Technologies has a 331 per cent upside, says Stifel

...
WELL is unique as a healthcare services and technology company with multiple levers to drive growth. The company expanded rapidly throughout the pandemic via M&A, including with over 30 transactions. The M&A pace has slowed recently and WELL has turned its attention on driving operational improvement and greater organic growth. Q3 results demonstrate this focus with 18 per cent organic growth with good EBITDA and cash generation, Keywood said.

With the update, Keywood maintained a “Buy” rating on WELL and one-year target price of $13.50, which at press time represented a projected return of 331 per cent.

The relatively new health-tech sector is volatile as many companies rushed to issue shares throughout the pandemic with frothy valuations to re-set substantially. WELL is much different than most peers with profitable growth and certain assets that have moat-like characteristics in Canada. The stock is trading at 1.6x 2022 sales and 1x the guided exit run- rate in 2023 versus mostly unprofitable peers at above 2x sales, Keywood wrote.
...
https://www.cantechletter.com/2022/11/well-health-technologi…

[winston-wolfe]

Well Health earns $611,000 in Q3 2022

Third quarter 2022 financial highlights:

Well achieved record quarterly revenue of $145.8-million in Q3 2022, compared with revenue of $99.3-million generated during Q3-2021, an increase of 47 per cent driven by acquisitions during the past year and organic growth;
Omnichannel patient services revenue increased 15 per cent to $93.6-million in Q3 2022, compared with $81.3-million in Q3 2021;
Virtual services revenues increased 191 per cent to $52.2-million in Q3 2022, compared with virtual services revenue of $18-million in Q3 2021;
Well achieved record adjusted gross profit of $78.2-million in Q3 2022, compared with adjusted gross profit of $50-million in Q3 2021, representing an increase of 56 per cent;
Well achieved adjusted gross margin percentage of 53.6 per cent during Q3 2022 compared with adjusted gross margin percentage of 50.3 per cent in Q3 2021;
Adjusted EBITDA was a record $27.5-million for Q3 2022, compared with adjusted EBITDA of $22.3-million in Q3 2021. Adjusted EBITDA was positively impacted in the quarter by an increase in revenue for the higher-margin virtual services businesses, in addition to healthy EBITDA margins in the company's omnichannel patient services;
Adjusted net income was $14.8-million, or seven cents per share, in Q3 2022 compared with adjusted net income of $9.8-million, or five cents per share, in Q3-2021.
Eva Fong, chief financial officer of Well, commented: "I am also pleased to report that Well is a profitable business that generated $11.4-million free cash flow during the quarter attributable to shareholders in Q3, which can be used to fund the company's future organic and inorganic growth. As we turn our attention to the next fiscal year, we can't help but be filled with optimism as our talented team is executing and delivering on our mission of supporting providers with best-in-class technology and operating solutions. For this reason, the company is pleased to announce it expects to approach $700-million in exit run-rate revenue by the end of 2023."
...
https://www.stockwatch.com/News/Item/Z-C!WELL-3327380/C/WELL

[winston-wolfe]

Das Ziel von WELL Health (WKN: A2JQV6) ist es, mit der besten und neuesten Technologie den Medizinmarkt zu revolutionieren und den Pflegestandard bei Ärzten und in Kliniken zu verbessern.

So viel zu den bescheidenen Zielen des Unternehmens. Ziel dieses Threads ist aktuelle Entwicklungen zu veröffentlichen und zu diskutieren.